Severe malnutrition and metabolic complications of HIV-infected children in the antiretroviral era: Clinical care and management in resource-limited settings

American Journal of Clinical Nutrition

Volumn 94, Issue 6, 2011, Pages

  Musoke, Philippa M ^a,d   Fergusson, Pamela ^b,c  

^a MAKERERE UNIVERSITY   (Uganda)

^b Food and Nutrition Technical Assistance II   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d MUJHU Care Limited   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COPPER; IODINE; IRON; MAGNESIUM; RETINOL; SELENIUM; ZINC;

BONE DENSITY; COMPARATIVE STUDY; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; INSULIN RESISTANCE; LACTIC ACIDOSIS; LIPODYSTROPHY; MALNUTRITION; MORBIDITY; MORTALITY; OSTEOPENIA; QUALITY OF LIFE; RISK FACTOR; SEVERE ACUTE MALNUTRITION; SURVIVAL; TREATMENT DURATION; VIRUS LOAD; VITAMIN SUPPLEMENTATION;

AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; DISEASE MANAGEMENT; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; METABOLIC DISEASES; NUTRITIONAL STATUS; POVERTY; PROTEIN-ENERGY MALNUTRITION;

EID: 82355163479     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.018374     Document Type: Conference Paper

References (39)

1. UNAIDS/WHO. 2010 Report on the global AIDS epidemic. Available from: www.unaids.org/globalreport/global-report.htm (cited 23 March 2011).
2. Obimbo EM, Mbori-Ngacha DA, Ochieng JO, Richardson BA, Otieno PA, Bosire R, Farquhar C, Overbaugh J, John-Stewart GC. Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected African children. Pediatr Infect Dis J 2004;23:536-43. (Pubitemid 38802299)
3. Gibb DM, Duong T, Tookey PA, Sharland M, Tudor-Williams G, Novelli V, Butler K, Riordan A, Farrelly L, Masters J, et al. National Study of HIV in Pregnancy and Childhood Collaborative HIV Paediatric Study. Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. BMJ 2003;327:1019.
4. Sauvageot D, Schaefer M, Olson D, Pujades-Rodriguez M, O'Brien DP. Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children <5 years of age. Pediatrics 2010;125:e1039-47.
5. Eley B. Metabolic complications of antiretroviral therapy in HIV-infected children. Expert Opin Drug Metab Toxicol 2008;4:37-49. (Pubitemid 351234099)
6. Fergusson P, Tomkins A. HIV prevalence and mortality among children undergoing treatment for severe acute malnutrition in sub-Saharan Africa: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg 2009;103:541-8.
7. Collins S, Dent N, Binns P, Bahwere P, Sadler K, Hallam A. Management of severe acute malnutrition in children. Lancet 2006;368:1992-2000. (Pubitemid 44821358)
8. Cross Continents Collaboration for Kids (3Csforkids) Analysis and Writing Committee. Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis. AIDS 2008;22:97-105.
9. Walker AS, Mulenga V, Sinyinza F, Lishimpi K, Nunn A, Chintu C, Gibb DM; CHAP Trial Team. Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial. J Acquir Immune Defic Syndr 2006;42:637-45. (Pubitemid 44162436)
10. Grinspoon S, Mulligan K. Weight loss and wasting in patients infected with human immunodeficiency virus. Clin Infect Dis 2003;36(suppl):S69-78. (Pubitemid 36408113)
11. WHO. Management of severe malnutrition: a manual for physicians and other senior health workers. Geneva, Switzerland: World Health Organization, 1999.
12. Bunn J, Thindwa M, Kerac M. Features associated with underlying HIV infection in severe acute childhood malnutrition: a cross sectional study. Malawi Med J 2009;21:108-12.
13. Buys H, Hendricks M, Eley B, Hussey G. The role of nutrition and micronutrients in paediatric HIV infection. SADJ 2002;57:454-6.
14. Irlam JH, Visser MM, Rollins NN, Siegfried N. Micronutrient supplementation in children and adults with HIV infection. Cochrane Database Syst Rev 2010;12:CD003650.
15. Diop el HI. Dossou NI, Ndour MM, Briend A, Wade S. Comparison of the efficacy of a solid ready-to-use food and a liquid, milk-based diet for the rehabilitation of severely malnourished children: a randomized trial. Am J Clin Nutr 2003;78:302-7.
16. Bachou H, Tumwine JK, Mwadime RK, Tylleskar T. Risk factors in hospital deaths in severely malnourished children in Kampala, Uganda. BMC Pediatr 2006;6:7.
17. + cell counts. Nutr J 2006;5:27.
18. Hughes SM, Amadi B, Mwiya M, Nkamba H, Mulundu G, Tomkins A, Goldblatt D. CD4 counts decline despite nutritional recovery in HIV-infected Zambian children with severe malnutrition. Pediatrics 2009;123:e347-51.
19. Oshikoya KA, Senbanjo IO. Pathophysiological changes that affect drug disposition in protein-energy malnourished children. Nutr Metab (Lond) 2009;6:50.
20. Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, Moss WJ. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis 2008;8:477-89. (Pubitemid 352005822)
21. Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics 2002;109:E25.
22. Musoke PM, Mudiope P, Barlow-Mosha LN, Ajuna P, Bagenda D, Mubiru MM, Tylleskar T, Fowler MG. Growth, immune and viral responses in HIV infected African children receiving highly active anti-retroviral therapy: a prospective cohort study. BMC Pediatr 2010;10:56.
23. Kekitiinwa A, Lee KJ, Walker AS, Maganda A, Doerholt K, Kitaka SB, Asiimwe A, Judd A, Musoke P, Gibb DM; Collaborative HIV Paediatric Study (CHIPS) Steering Committe; Mulago Cohort Team. Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. J Acquir Immune Defic Syndr 2008;49:384-92.
24. Peacock-Villada E, Richardson BA, John-Stewart GC. Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countries. Pediatrics 2011;127:e423-41.
25. Prendergast A, Bwakura-Dangarembizi M, Cook A, Bakeera-Kitaka S, Natukunda E, Nahirya Ntege P, Nathoo KJ, Karungi C, Lutaakome J, Kekitiinwa A, et al. Hospitalization for severe malnutrition among HIV-infected children starting antiretroviral therapy. AIDS 2011:25:951-6.
26. Kim RJ, Rutstein RM. Impact of antiretroviral therapy on growth, body composition and metabolism in pediatric HIV patients. Paediatr Drugs 2010;12:187-99.
27. Barbaro G. Highly active antiretroviral therapy-associated metabolic syndrome: pathogenesis and cardiovascular risk. Am J Ther 2006;13:248-60. (Pubitemid 44026193)
28. Taylor P, Worrell C, Steinberg SM, Hazra R, Jankelevich S, Wood LV, Zwerski S, Yarchoan R, Zeichner S. Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens. Pediatrics 2004;114:e235-42.
29. Arpadi SM, Bethel J, Horlick M, Sarr M, Bamji M, Abrams EJ, Purswani M, Engelson ES. Longitudinal changes in regional fat content in HIV-infected children and adolescents. AIDS 2009;23:1501-9.
30. Viganò A, Mora S. Adverse effects of antiretroviral therapy: focus on bone density. Expert Opin Drug Saf 2004;3:199-208.
31. Innes S, Levin L, Cotton M. Lipodystrophy syndrome in Hiv-infected children on HAART. South Afr J HIV Med 2009;10:76-80.
32. Aurpibul L, Puthanakit T, Lee B, Mangklabruks A, Sirisanthana T, Sirisanthana V. Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Antivir Ther 2007;12:1247-54.
33. Parakh A, Dubey AP, Kumar A, Maheshwari A. Lipodystrophy and metabolic complications of highly active antiretroviral therapy. Indian J Pediatr 2009;76:1017-21.
34. Sivakumar T, Mechanic O, Fehmie D, Paul B. Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials. HIV Med 2011;12:453-62.
35. Hartman K, Verweel G, de Groot R, Hartwig NG. Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy. Pediatr Infect Dis J 2006;25:427-31.
36. Lakshmy R, Gupta R, Prabhakaran D, Snehi U, Reddy KS. Utility of dried blood spots for measurement of cholesterol and triglycerides in a surveillance study. J Diabetes Sci Technol 2010;4:258-62.
37. Jacobson DL, Spiegelman D, Duggan C, Weinberg GA, Bechard L, Furuta L, Nicchitta J, Gorbach SL, Miller TL. Predictors of bone mineral density in human immunodeficiency virus-1 infected children. J Pediatr Gastroenterol Nutr 2005;41:339-46. (Pubitemid 41285829)
38. Mora S, Sala N, Bricalli D, Zuin G, Chiumello G, Vigano A. Bone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral therapy. AIDS 2001;15:1823-9. (Pubitemid 32939243)
39. Zuccotti G, Vigano A, Gabiano C, Giacomet V, Mignone F, Stucchi S, Manfredini V, Marinacci F, Mora S. Antiretroviral therapy and bone mineral measurements in HIV-infected youths. Bone 2010;46:1633-8.